Medical Device Contract Manufacturing Market, 2030 - ResearchAndMarkets.com

DUBLIN--()--The "Medical Device Contract Manufacturing Market, 2019-2030" report has been added to ResearchAndMarkets.com's offering.

Medical Device Contract Manufacturing Market is Estimated to Reach a Net Worth of Approximately USD 430 Billion in 2020

The Medical Device CMOs Market, 2019-2030 report features a comprehensive study on the current landscape of contract manufacturing service providers focused on medical devices (specifically for drug-delivery devices, diagnostic devices, and therapeutic devices). The scope of the report primarily includes those manufacturers that offer finished product services for medical devices (excluding medical equipment, such as X-ray machines, ultrasound machines, operating tables, and other similar products).

Recent advances in data science technology solutions, such as Internet of Things, machine learning, artificial intelligence, and real-world evidence-based solutions, have enabled medical device developers to digitize and automate a number of product development and manufacturing processes.

However, most developers lack adequate resources and the necessary expertise to manufacture medical devices and related components. Moreover, given the rapid rate of evolution, the costs associated with acquiring the necessary infrastructure and capabilities in this field are high; therefore, it is difficult for companies with limited finances to acquire such resources and carry out such operations by themselves.

In addition, the evolving regulatory guidelines and complicated pathways to establishing reimbursement strategies render medical devices subject to rigorous quality assessments, especially for medium and high-risk devices. The aforementioned constraints have led many of the smaller players and certain established players to outsource a significant part of their manufacturing operations to capable contract manufacturing organizations (CMOs). CMOs are known to offer significant cost-benefits, access to sophisticated/up-to-date infrastructure, large production capacities and reduction in time-to-market.

Given the demand for medical devices, the opportunity for CMOs with expertise in medical devices is steadily rising. In fact, in 2018 alone, the USFDA approved over 100 medical devices. It is worth highlighting that, since 2000, more than 65 CMOs have been established. The demand for one-stop-shops and versatile supply chain management solutions have fuelled consolidation activity in this domain.

Contemporary contract service providers have been focusing on bolstering in-house capabilities to offer a wider range of services to their clients, covering product design to distribution and marketing, along with regulatory assistance. The medical device sector is among the most highly regulated industries, and we expect the demand for core competencies, such as design and engineering, prototype development and high volume manufacturing, to continue to drive sponsor companies to outsource various parts of their product development and manufacturing operations to capable contract service providers. Amidst tough competition, the availability of advanced tools and technologies is an important differentiating factor; CMOs that invest in such upgrades are likely to gain a competitive edge.

Key Topics Covered:

1. PREFACE

1.1. Scope of the Report

1.2. Research Methodology

1.3. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION

3.1. Chapter Overview

3.2. Overview of Medical Devices

3.2.1. History of Medical Devices

3.2.2. Classification of Medical Devices

3.3. Overview of Medical Device Manufacturing

3.3.1. Associated Challenges

3.3.2. Role of Contract Manufacturing Organizations (CMOs)

3.3.3. Role of Automation

3.4. Overview of Medical Device CMOs

3.5. Services Offered by Medical Device CMOs

3.6. Advantages of Medical Device CMOs

3.7. Risks Associated with Outsourcing Manufacturing Operations

3.8. Key Considerations for Selecting a CMO Partner

3.9. Concluding Remarks

4. MEDICAL DEVICE REGULATORY LANDSCAPE

4.1. Chapter Overview

4.2. General Regulatory Guidelines for Medical Devices

5. MARKET OVERVIEW: THERAPEUTIC DEVICES

5.1. Chapter Overview

5.2. Medical Device CMOs Offering Services for Therapeutic Devices

6. MARKET OVERVIEW: DIAGNOSTIC DEVICES

6.1. Chapter Overview

6.2. Medical Device CMOs Offering Services for Diagnostic Devices

7. MARKET OVERVIEW: DRUG-DELIVERY DEVICES AND OTHERS

7.1. Chapter Overview

7.2. Medical Device CMOs Offering Services for Drug Delivery Devices

7.3. Medical Device CMOs Offering Services for Other Devices

8. BENCHMARK ANALYSIS

8.1. Chapter Overview

8.2. Benchmark Analysis: Methodology

8.3. Region-wise Benchmark Analysis

9. SUPPLY CHAIN ANALYSIS

9.1. Chapter Overview

9.2. Overview of Medical Device Value Chain

9.2.1. Value Chain versus Supply Chain

9.3 Factors Affecting the Medical Device Supply Chain

9.4. Supply Chain Improvement Strategies

9.5. Key Performance Indicators

9.6. Visible Supply Chain and Related Advantages

9.6.1. Augmenting Supply Chain Visibility Through Digitalization

9.6.1.1. Benefits of Digital Supply Chain Management

9.7. Supply Chain Optimization

10. COMPANY PROFILES

10.1. Chapter Overview

10.2. CMOs Headquartered in North America

10.2.1. Cirtec Medical

10.2.2. DynaFlex Technologies

10.2.3. I-Tek Medical Technologies

10.2.4. Keystone Solutions Group

10.2.5. Oscor

10.2.6. SMC

10.2.7. Stellartech

10.3. CMOs Headquartered in Europe

10.3.1. Creganna Medical

10.3.2. Europlaz Technologies

10.3.3. Riverside Medical Packaging

10.3.4. Synecco

10.3.5. Trelleborg Sealing Solutions

10.4. CMOs Headquartered in Asia

10.4.1. Interplex

10.4.2. Modern Medical

10.4.3. Providence Enterprise

10.4.4. Suzhou Jenitek

11. CLINICAL TRIAL ANALYSIS

11.1. Chapter Overview

11.2. Scope and Methodology

11.3. Clinical Trial Analysis: Word Cloud of Trial Titles

11.4. Analysis of Clinical Trials

11.4.1. Analysis by Trial Start Year

11.4.2. Analysis by Trial Status

11.4.3. Analysis by Phase of Development

11.4.4. Analysis by Target Indication

11.4.5. Analysis by Type of Sponsor

11.4.6. Analysis by Geography

11.4.7. Analysis by Trial Start Year and Geography

11.5. Analysis of Enrolled Patient Population

11.6. Analysis of Focus Therapeutic Areas

11.6.1. Analysis by Type of Sponsor

11.6.2. Analysis by Geography

11.6.3. Cardiovascular Disorders

11.6.4. Oncological Disorders

11.6.5. Central Nervous System (CNS) Disorders

11.6.6. Orthopedic Disorders

11.6.7. Respiratory Disorders

12. MERGERS & ACQUISITIONS

12.1. Chapter Overview

12.2. Acquisition Models

12.3. Medical Device Contract Manufacturing Market: Mergers and Acquisitions

12.3.1. Analysis by Year of Mergers and Acquisitions

12.3.2. Analysis by Type of Acquisition

12.3.3. Most Active Acquirers: Analysis by Number of Acquisitions

12.3.4. Analysis by Key Value Drivers

12.3.4.1. Analysis by Key Value Drivers and Year of Acquisition

12.3.5. Analysis by Type of Device

12.3.5.1. Analysis by Type of Device and Key Value Drivers

12.3.6. Analysis by Therapeutic Area

12.3.7. Analysis by Type of Services Offered

12.3.8. Regional Analysis

12.3.8.1. Continent-wise Distribution

12.3.8.2. Country-wise Distribution

12.3.8.3. Intercontinental and Intracontinental Deals

12.4. Key Acquisitions: Deal Multiples

12.4.1. Relationship between Deal Multiples

13. CASE STUDY: OFFSHORING MEDICAL DEVICE CONTRACT MANUFACTURING

13.1. Chapter Overview

13.2. Emerging Markets: Definitions and Key Regions

13.3. Global Manufacturing Market: Role of Emerging Markets

13.3.1. Contributions to the Automobile Industry

13.3.2. Contributions to the Aerospace and Defence Industries

13.4. Overview of Medical Device Manufacturing in Emerging Markets

13.4.1. The US-Chinese Scenario

13.4.2. Comparative Analysis between Developed Regions and Emerging Markets

13.4.3. Partnerships with Companies in Emerging Markets

13.5. Medical Device-focused Multinational Companies in Emerging Markets

13.6. Medical Device Manufacturing Business Models Used in Emerging Markets

13.6.1. Case Studies

13.7. Innovation in Medical Device Industry: Key Challenges

13.7.1. Limitations of In-House Innovation

13.8. Advantages of Establishing Innovation Hubs in Emerging Markets

13.8.1. Challenges and Market Restraints

13.8.2. Strategies to Address Existing Challenges

13.9. Future Perspectives

14. MARKET FORECAST

14.1. Chapter Overview

14.2. Forecast Methodology and Key Assumptions

14.3. Overall Medical Device Contract Manufacturing Market, 2019-2030

14.4. Medical Device Contract Manufacturing Market: Distribution by Geography, 2019 and 2030

15. SWOT ANALYSIS

16. CONCLUSION

17. SURVEY / INTERVIEW TRANSCRIPTS

18. APPENDIX 1: TABULATED DATA

19. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

For more information about this report visit https://www.researchandmarkets.com/r/l0g9fr

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Medical Devices

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Medical Devices